Orchid Pharma Limited · NSE:ORCHPHARMA

Orchid Pharma — Q1 FY2024-25 Earnings Presentation

9 slides from Orchid Pharma's earnings presentation, Aug 13, 2024

  1. Slide 1: Stock exchange intimation letter: Investors Presentation Q1 FY 2024-25

    August 13, 2024 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai-400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref: Regulation 30 of Securities and Exchange Board of India (Listin

  2. Slide 2: Orchid Pharma Limited Financials Q1 & FY 2024-25

    Orchid Pharma Limited Financials Q1 & FY 2024-25 • All results in Standalone basis. • These are approx. nos. for exact nos. pls refer financials.

  3. Slide 3: Financial Highlights QTR-1

    Financial Highlights QTR-1 FY 23-24 34% 23% 71% 37% 169% 472% 169% 72%

  4. Slide 4: Financial Performance Summary

    Financial Performance Summary (Rs/Crore) Q1-2025 Q1-2024 Change % 12M-31st Mar’24 Sales 244.4 182.9 +34% 819.4 Other Income 7.8 1.9 30.4 COGS 150.3 112.1 484.6 Employee Exp 21.4 16.2 69.6 Other Exp 39.5 32.5 154.6 EBITDA 41.0 24.0 +71% 141.0 % to Sales 17% 13% 17% Interest 3.5 5.5 -36% 16.3 Deprecia

  5. Slide 5: Turnover (In Cr.)

    Turnover (In Cr.) 300.0 244.4 250.0 200.0 182.9 150.0 131.0 113.0 95.5 100.0 50.0 - Q1-21 Q1-22 Q1-23 Q1-24 Q1-25

  6. Slide 6: EBITDA, PBT & PAT as % to Sales Q1-25

    EBIDTA, PBT & PAT as % to Sales Q1-25 120.0% 100.0% 80.0% 60.0% 40.0% 22.2% 13.1% 16.8% 20.0% 7.9% 11.7% 0.0% 11.9% 5.9% -20.0% -14.4% -10.8% -24.6% -40.0% Q1-21 Q1-22 Q1-23 Q1-24 Q1-25 EBITDA PBT & PAT

  7. Slide 7: P&L Analysis – Gross Margin % to Sales

    P&L Analysis – Gross Margin % to Sales Gross Margin for Quarterly 60.0% 56.3% 49.8% 50.0% 46.7% 38.7% 38.5% 40.0% 30.0% 20.0% 10.0% 0.0% Q1-21 Q1-22 Q1-23 Q1-24 Q1-25

  8. Slide 8: P&L Analysis – Exp. % to Sales Q1-25

    P&L Analysis – Exp. % to Sales Q1-25 35.0% 30.2% 30.0% 26.1% 25.0% 21.2% 20.0% 17.8% 15.1% 16.2% 14.0% 15.0% 11.1% 10.0% 8.9% 8.8% 5.0% 0.0% Q1-21 Q1-22 Q1-23 Q1-24 Q1-25 Emp Benefit Other Exp

  9. Slide 9: Thank You

    Thank You

Orchid Pharma — Q1 FY2024-25 Earnings Presentation on 6ix